• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    Arcadia Biosciences (RKDA) Announces Date of First Quarter 2025 Financial Results and Business Highlights Conference Call

    4/29/25 8:02:00 AM ET
    $RKDA
    Farming/Seeds/Milling
    Consumer Staples
    Get the next $RKDA alert in real time by email

    DALLAS, April 29, 2025 (GLOBE NEWSWIRE) -- Arcadia Biosciences, Inc.® (NASDAQ:RKDA), a producer and marketer of innovative, plant-based health and wellness products, today announced that it will release its financial and business results for the first quarter of 2025 on May 8, 2025.

    The company has scheduled a conference call for 2:00 p.m. Eastern time (11:00 a.m. Pacific time) to discuss first-quarter results and key strategic achievements. Interested participants can join the conference call using the following options:

    • An audio-only webcast of the conference call will be available, with a link posted in the Investors section of Arcadia's website.

    • To join the live call, please register here, and a dial-in number and unique PIN will be provided.

    Following completion of the call, a recorded replay will be available in the Investors Section of the company's website.

    About Arcadia Biosciences, Inc.

    Since 2002, Arcadia Biosciences (NASDAQ:RKDA) has been innovating high-value, healthy ingredients to meet consumer demands for healthier choices. With its roots in agricultural innovation, Arcadia cultivates next-generation wellness products. For more information, visit www.arcadiabio.com.

    Arcadia Biosciences Contact:

    T.J. Schaefer

    [email protected]



    Primary Logo

    Get the next $RKDA alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $RKDA

    DatePrice TargetRatingAnalyst
    1/3/2022$7.00 → $6.00Buy
    HC Wainwright & Co.
    More analyst ratings

    $RKDA
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • SEC Form 4 filed by Chief Financial Officer Kawakami Mark

      4 - Arcadia Biosciences, Inc. (0001469443) (Issuer)

      5/12/25 8:56:01 PM ET
      $RKDA
      Farming/Seeds/Milling
      Consumer Staples
    • SEC Form 4 filed by Chief Executive Officer Schaefer Thomas J.

      4 - Arcadia Biosciences, Inc. (0001469443) (Issuer)

      5/12/25 8:48:31 PM ET
      $RKDA
      Farming/Seeds/Milling
      Consumer Staples
    • Chief Financial Officer Kawakami Mark bought $1,743 worth of shares (700 units at $2.49), increasing direct ownership by 35% to 2,681 units (SEC Form 4)

      4 - Arcadia Biosciences, Inc. (0001469443) (Issuer)

      2/5/25 7:34:41 PM ET
      $RKDA
      Farming/Seeds/Milling
      Consumer Staples

    $RKDA
    SEC Filings

    See more
    • Arcadia Biosciences Inc. filed SEC Form 8-K: Regulation FD Disclosure, Other Events, Financial Statements and Exhibits

      8-K - Arcadia Biosciences, Inc. (0001469443) (Filer)

      5/16/25 5:21:37 PM ET
      $RKDA
      Farming/Seeds/Milling
      Consumer Staples
    • SEC Form 10-Q filed by Arcadia Biosciences Inc.

      10-Q - Arcadia Biosciences, Inc. (0001469443) (Filer)

      5/8/25 8:07:59 AM ET
      $RKDA
      Farming/Seeds/Milling
      Consumer Staples
    • SEC Form 425 filed by Arcadia Biosciences Inc.

      425 - Arcadia Biosciences, Inc. (0001469443) (Subject)

      5/8/25 8:06:33 AM ET
      $RKDA
      Farming/Seeds/Milling
      Consumer Staples

    $RKDA
    Financials

    Live finance-specific insights

    See more
    • Arcadia Biosciences (RKDA) Announces First Quarter 2025 Financial Results and Business Highlights

      -- Revenues increase 22% year over year driven by 90% growth in Zola® ---- Arcadia sells patents for $750K and eliminates $1M in liabilities ---- Roosevelt agreement amended to provide greater certainty regarding exchange ratio -- DALLAS, May 08, 2025 (GLOBE NEWSWIRE) -- Arcadia Biosciences, Inc.® (NASDAQ:RKDA), a producer and marketer of innovative, plant-based health and wellness products, today released its financial and business results for the first quarter of 2025. The company has scheduled a conference call at 2:00 p.m. Eastern time (11:00 a.m. Pacific time) to discuss first-quarter results and key strategic achievements. "The momentum we experienced in the second half of 2024 has

      5/8/25 8:02:00 AM ET
      $RKDA
      Farming/Seeds/Milling
      Consumer Staples
    • Arcadia Biosciences (RKDA) Announces Date of First Quarter 2025 Financial Results and Business Highlights Conference Call

      DALLAS, April 29, 2025 (GLOBE NEWSWIRE) -- Arcadia Biosciences, Inc.® (NASDAQ:RKDA), a producer and marketer of innovative, plant-based health and wellness products, today announced that it will release its financial and business results for the first quarter of 2025 on May 8, 2025. The company has scheduled a conference call for 2:00 p.m. Eastern time (11:00 a.m. Pacific time) to discuss first-quarter results and key strategic achievements. Interested participants can join the conference call using the following options: An audio-only webcast of the conference call will be available, with a link posted in the Investors section of Arcadia's website.To join the live call, please register

      4/29/25 8:02:00 AM ET
      $RKDA
      Farming/Seeds/Milling
      Consumer Staples
    • Arcadia Biosciences (RKDA) Announces Fourth-Quarter and Full-Year 2024 Financial Results and Business Highlights

      -- Year-over-year revenues grew 56% in Q4 and 13% for full year -- -- Zola® year-over-year revenues increased 124% in Q4 and 46% for full year -- -- Company plans business combination with Roosevelt Resources, Inc. -- Arcadia Biosciences, Inc.® (NASDAQ:RKDA), a producer and marketer of innovative, plant-based health and wellness products, today released its financial and business results for the fourth quarter and full year of 2024. "We are extremely pleased with the progress we made in 2024, particularly in the second half of the year following the sale of our GoodWheat™ assets," said T.J. Schaefer, president and CEO. "Our focus on Zola® coconut water led to 80 percent revenue growth f

      3/20/25 4:05:00 PM ET
      $RKDA
      Farming/Seeds/Milling
      Consumer Staples

    $RKDA
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Arcadia Biosciences (RKDA) Announces First Quarter 2025 Financial Results and Business Highlights

      -- Revenues increase 22% year over year driven by 90% growth in Zola® ---- Arcadia sells patents for $750K and eliminates $1M in liabilities ---- Roosevelt agreement amended to provide greater certainty regarding exchange ratio -- DALLAS, May 08, 2025 (GLOBE NEWSWIRE) -- Arcadia Biosciences, Inc.® (NASDAQ:RKDA), a producer and marketer of innovative, plant-based health and wellness products, today released its financial and business results for the first quarter of 2025. The company has scheduled a conference call at 2:00 p.m. Eastern time (11:00 a.m. Pacific time) to discuss first-quarter results and key strategic achievements. "The momentum we experienced in the second half of 2024 has

      5/8/25 8:02:00 AM ET
      $RKDA
      Farming/Seeds/Milling
      Consumer Staples
    • Arcadia Biosciences (RKDA) Announces Date of First Quarter 2025 Financial Results and Business Highlights Conference Call

      DALLAS, April 29, 2025 (GLOBE NEWSWIRE) -- Arcadia Biosciences, Inc.® (NASDAQ:RKDA), a producer and marketer of innovative, plant-based health and wellness products, today announced that it will release its financial and business results for the first quarter of 2025 on May 8, 2025. The company has scheduled a conference call for 2:00 p.m. Eastern time (11:00 a.m. Pacific time) to discuss first-quarter results and key strategic achievements. Interested participants can join the conference call using the following options: An audio-only webcast of the conference call will be available, with a link posted in the Investors section of Arcadia's website.To join the live call, please register

      4/29/25 8:02:00 AM ET
      $RKDA
      Farming/Seeds/Milling
      Consumer Staples
    • Arcadia Biosciences (RKDA) Announces Fourth-Quarter and Full-Year 2024 Financial Results and Business Highlights

      -- Year-over-year revenues grew 56% in Q4 and 13% for full year -- -- Zola® year-over-year revenues increased 124% in Q4 and 46% for full year -- -- Company plans business combination with Roosevelt Resources, Inc. -- Arcadia Biosciences, Inc.® (NASDAQ:RKDA), a producer and marketer of innovative, plant-based health and wellness products, today released its financial and business results for the fourth quarter and full year of 2024. "We are extremely pleased with the progress we made in 2024, particularly in the second half of the year following the sale of our GoodWheat™ assets," said T.J. Schaefer, president and CEO. "Our focus on Zola® coconut water led to 80 percent revenue growth f

      3/20/25 4:05:00 PM ET
      $RKDA
      Farming/Seeds/Milling
      Consumer Staples

    $RKDA
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Chief Financial Officer Kawakami Mark bought $1,743 worth of shares (700 units at $2.49), increasing direct ownership by 35% to 2,681 units (SEC Form 4)

      4 - Arcadia Biosciences, Inc. (0001469443) (Issuer)

      2/5/25 7:34:41 PM ET
      $RKDA
      Farming/Seeds/Milling
      Consumer Staples
    • Chief Executive Officer Schaefer Thomas J. bought $1,743 worth of shares (700 units at $2.49), increasing direct ownership by 33% to 2,819 units (SEC Form 4)

      4 - Arcadia Biosciences, Inc. (0001469443) (Issuer)

      2/5/25 7:24:18 PM ET
      $RKDA
      Farming/Seeds/Milling
      Consumer Staples
    • Chief Financial Officer Kawakami Mark bought $1,442 worth of shares (700 units at $2.06), increasing direct ownership by 55% to 1,981 units (SEC Form 4)

      4 - Arcadia Biosciences, Inc. (0001469443) (Issuer)

      8/20/24 8:11:11 PM ET
      $RKDA
      Farming/Seeds/Milling
      Consumer Staples